Technical Feasibility of Tissue Microarray (TMA) analysis of tumor-associated immune response in prostate cancer

Timothy J. Wallace, Junqi Qian, Itzhak Avital, Curt Bay, Yan Gao Man, Laurie L. Wellman, Chris Moskaluk, Dean Troyer, Dharam Ramnani, Alexander Stojadinovic

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Introduction: The androgen receptor (AR) regulates immune-related epithelial-to-mesenchymal transition (EMT), and prostate cancer (PCa) metastasis. Primary tumor-infiltrating lymphocytes (TILs) [CD3+, CD4+, and CD8+ TILs] are potential prognostic indicators in PCa, and variations may contribute to racial disparities in tumor biology and PCa outcomes. Aim: To assess the technical feasibility of tumor microarray (TMA)-based methods to perform multi-marker TIL profiling in primary resected PCa. Methods: Paraffin-embedded tissue cores of histopathologically-confirmed primary PCa (n = 40; 1 TMA tissue specimen loss) were arrayed in triplicate on TMAs. Expression profiles of AR, CD3+, CD4+, and CD8+ TILs in normal prostate, and the center and periphery of both the tumor-dominant nodule and highest Gleason grade were detected by IHC and associated with clinical and pathological data using standard statistical methodology. An independent pathologist, blinded to the clinical data, scored all samples (percent and intensity of positive cells). Results: TMAs were constructed from 21 (53.8%) Black and 18 (46.2%) White males with completely-resected, primarily pT2 stage PCa [pT2a (n = 3; 7.7%); pT2b (n = 2; 5.1%); pT2c (n = 27; 69.2%); pT3a (n = 5; 12.8%); mean pre-op PSA = 8.17 ng/ml]. The CD3, CD4, CD8, and CD8/CD3 cellular protein expression differed from normal in the periphery of the dominant nodule, the center of the highest Gleason grade, and the periphery of the highest Gleason grade (P < 0.05). Correlations between TIL expression in the center and periphery of the dominant nodule, with corresponding center and periphery of the highest Gleason grade, respectively, were robust, and the magnitude of these correlations differed markedly by race (P < 0.05). Conclusions: Multi-marker (AR, CD3, CD4, CD8) profiling with IHC analysis of TMAs consisting of primary, non-metastatic resected prostate cancer is technically feasible in this pilot study. Future studies will evaluate primary tumor immunoscore using semi-quantitative, IHC-based methodology to assess differences in the spectrum, quantity, and/or localization of TILs, and to gain insights into racial disparities in PCa tumor biology and clinical outcomes.

Original languageEnglish
Pages (from-to)2191-2202
Number of pages12
JournalJournal of Cancer
Volume9
Issue number12
DOIs
StatePublished - 1 Jan 2018
Externally publishedYes

Keywords

  • Androgen receptor
  • Immunoscore
  • Prostate cancer
  • Tissue microarray
  • Tumor-infiltrating lymphocytes

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Technical Feasibility of Tissue Microarray (TMA) analysis of tumor-associated immune response in prostate cancer'. Together they form a unique fingerprint.

Cite this